Cholesterol emboli syndrome other diagnostic studies: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 4: Line 4:
==Overview==
==Overview==
== Other Diagnostic Studies ==
== Other Diagnostic Studies ==
* Biopsy of lesions can definitely establish the diagnosis of [[cholesterol emboli syndrome]]<ref name="JucglaMoreso2006">{{cite journal|last1=Jucgla|first1=Anna|last2=Moreso|first2=Francesc|last3=Muniesa|first3=Cristina|last4=Moreno|first4=Abelardo|last5=Vidaller|first5=Antonio|title=Cholesterol embolism: Still an unrecognized entity with a high mortality rate|journal=Journal of the American Academy of Dermatology|volume=55|issue=5|year=2006|pages=786–793|issn=01909622|doi=10.1016/j.jaad.2006.05.012}}</ref><ref>{{cite journal|doi=10.1055/s-0032-1305005.}}</ref>
* Biopsy of lesions can definitely establish the diagnosis of [[cholesterol emboli syndrome]].<ref name="JucglaMoreso2006">{{cite journal|last1=Jucgla|first1=Anna|last2=Moreso|first2=Francesc|last3=Muniesa|first3=Cristina|last4=Moreno|first4=Abelardo|last5=Vidaller|first5=Antonio|title=Cholesterol embolism: Still an unrecognized entity with a high mortality rate|journal=Journal of the American Academy of Dermatology|volume=55|issue=5|year=2006|pages=786–793|issn=01909622|doi=10.1016/j.jaad.2006.05.012}}</ref><ref>{{cite journal|doi=10.1055/s-0032-1305005.}}</ref>
*:*On biposy from [[skin]], [[muscle]], [[kidney]] or [[gastrointestinal tract]], [[cholesterol emboli syndrome] is characterized by [[cholesterol crystals]].<ref>{{cite journal|doi=10.1055/s-0032-1305005.}}</ref>
**On biposy from [[skin]], [[muscle]], [[kidney]] or [[gastrointestinal tract]], [[cholesterol emboli syndrome] is characterized by [[cholesterol crystals]].<ref>{{cite journal|doi=10.1055/s-0032-1305005.}}</ref><ref name="ParafJacquot2001">{{cite journal|last1=Paraf|first1=Francois|last2=Jacquot|first2=Christian|last3=Bloch|first3=Francis|last4=Montpreville|first4=Vincent|last5=Bruneval|first5=Patrick|title=Cholesterol crystal embolization demonstrated on GI biopsy|journal=The American Journal of Gastroenterology|volume=96|issue=12|year=2001|pages=3301–3304|issn=0002-9270|doi=10.1111/j.1572-0241.2001.05329.x}}</ref>
<ref name="ParafJacquot2001">{{cite journal|last1=Paraf|first1=Francois|last2=Jacquot|first2=Christian|last3=Bloch|first3=Francis|last4=Montpreville|first4=Vincent|last5=Bruneval|first5=Patrick|title=Cholesterol crystal embolization demonstrated on GI biopsy|journal=The American Journal of Gastroenterology|volume=96|issue=12|year=2001|pages=3301–3304|issn=0002-9270|doi=10.1111/j.1572-0241.2001.05329.x}}</ref>
** Biopsy of affected organs shows characteristic changes in about half to 75% the clinically diagnosed cases.
*:* Biopsy of affected organs shows characteristic changes in about half to 75% the clinically diagnosed cases.
** Biopsy of skin lesions is often revealing in patients with [[cutaneous]] involvement.  
*:* Biopsy of skin lesions is often revealing in patients with cutaneous involvement.  
** Transverse sections of affected [[arterioles]], show occlusion of the lumen by biconvex needle-shaped [[cholesterol crystal]]s, which dissolve during histologic processing to leave clefts, surrounded by fibrin and [[platelet thrombi]], sometimes in association with foreign-body [[giant cells]] and [[intimal]] thickening.
*:* Transverse sections of affected arterioles, show occlusion of the lumen by biconvex needle-shaped [[cholesterol crystal]]s, which dissolve during histologic processing to leave clefts, surrounded by fibrin and platelet thrombi, sometimes in association with foreign-body giant cells and intimal thickening.


==References==
==References==

Latest revision as of 22:44, 19 February 2021

Cholesterol emboli syndrome Microchapters

Home

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Cholesterol emboli syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cholesterol emboli syndrome other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cholesterol emboli syndrome other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cholesterol emboli syndrome other diagnostic studies

CDC on Cholesterol emboli syndrome other diagnostic studies

Cholesterol emboli syndrome other diagnostic studies in the news

Blogs on Cholesterol emboli syndrome other diagnostic studies

Directions to Hospitals Treating Cholesterol emboli syndrome

Risk calculators and risk factors for Cholesterol emboli syndrome other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Other Diagnostic Studies

References

  1. Jucgla, Anna; Moreso, Francesc; Muniesa, Cristina; Moreno, Abelardo; Vidaller, Antonio (2006). "Cholesterol embolism: Still an unrecognized entity with a high mortality rate". Journal of the American Academy of Dermatology. 55 (5): 786–793. doi:10.1016/j.jaad.2006.05.012. ISSN 0190-9622.
  2. . doi:10.1055/s-0032-1305005. Check |doi= value (help). Missing or empty |title= (help)
  3. . doi:10.1055/s-0032-1305005. Check |doi= value (help). Missing or empty |title= (help)
  4. Paraf, Francois; Jacquot, Christian; Bloch, Francis; Montpreville, Vincent; Bruneval, Patrick (2001). "Cholesterol crystal embolization demonstrated on GI biopsy". The American Journal of Gastroenterology. 96 (12): 3301–3304. doi:10.1111/j.1572-0241.2001.05329.x. ISSN 0002-9270.


Template:WikiDoc Sources